Calendar

Sep
26
Tue
Summit Meeting – St. Louis, MO @ Marriott St. Louis Grand
Sep 26 @ 6:00 pm – 8:00 pm

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

Tuesday, September 26, 2017

5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting

Marriott St. Louis Grand
800 Washington Avenue
St. Louis, MO 63101
Meeting Room: Hawthorne/Lucas/Flora

PROGRAM FEATURES

  • Create your own Personalized Poster
  • Interactive, case-based learning environment
  • iPads provided to enhance learning experience
  • 3D videos and glasses provided for all attendees

FACULTY

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

M. Susan Burke, MD, FACP
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, PA

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
  • Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
  • Discuss the established acute and preventive therapeutic options for patients with migraine.
  • Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

PHARMACISTS

Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of  continuing pharmacy education.  Successful completion of this program qualifies for up to 2 contact hours.  Full attendance is required.  No partial contact hours will be awarded for partial attendance. UAN:0453-9999-17-348-L04(K)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Oct
5
Thu
Summit Meeting – Dallas, TX @ W Dallas – Victory
Oct 5 @ 6:00 pm – 8:00 pm

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

Thursday, October 05, 2017

5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting

W Dallas – Victory
2440 Victory Park Ln
Dallas, TX, 75219
Meeting Room: Altitude

PROGRAM FEATURES

  • Create your own Personalized Poster
  • Interactive, case-based learning environment
  • iPads provided to enhance learning experience
  • 3D videos and glasses provided for all attendees

FACULTY

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

M. Susan Burke, MD, FACP
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, PA

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
  • Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
  • Discuss the established acute and preventive therapeutic options for patients with migraine.
  • Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Oct
6
Fri
Grand Rounds – Fort Worth, TX @ Texas Health Huguley Hospital
Oct 6 @ 12:00 pm – 1:00 pm

Location:

Texas Health Huguley
11801 S. Freeway / PO Box 6337
Fort Worth, TX 76115

Meeting Room:
Tower A, 3rd FL Conference Room

Speaker:

Frederick R. Taylor, MD FAAN FAHS
Professor of Clinical Neurology
University of Minnesota Medical School
Minneapolis, MN

Oct
10
Tue
Summit Meeting – Philadelphia, PA @ Courtyard Philadelphia Downtown
Oct 10 @ 6:00 pm – 8:00 pm

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

Tuesday, October 10, 2017

5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting

Courtyard Philadelphia Downtown
21 North Juniper Street
Philadelphia, PA, 19107
Meeting room: Juniper Ballroom

PROGRAM FEATURES

  • Create your own Personalized Poster
  • Interactive, case-based learning environment
  • iPads provided to enhance learning experience
  • 3D videos and glasses provided for all attendees

FACULTY

Stephen D. Silberstein, MD
Professor of Neurology
Director, Jefferson Headache Center
Thomas Jefferson University
Philadelphia, PA

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
  • Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
  • Discuss the established acute and preventive therapeutic options for patients with migraine.
  • Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Oct
18
Wed
Grand Rounds – Dallas, TX @ Dallas VA Medical Center
Oct 18 @ 12:00 pm – 1:00 pm

Location:

Dallas VA Medical Center
4500 S. Lancaster Rd.
Dallas, TX 75216

Speaker:

Frederick R. Taylor, MD FAAN FAHS
Professor of Clinical Neurology
University of Minnesota Medical School
Minneapolis, MN

Oct
25
Wed
Grand Rounds – Houston, TX @ Park Plaza Specialty Hospital
Oct 25 @ 12:00 pm – 1:00 pm

Location:

1313 Hermann Dr.
Houston, TX 77004
Meeting Room: Doctor’s Dining Room, 1st Floor South Tower

Speaker:

Frederick R. Taylor, MD FAAN FAHS
Professor of Clinical Neurology
University of Minnesota Medical School
Minneapolis, MN

Summit Meeting – Cincinnati, OH @ Cincinnati Marriott at RiverCenter
Oct 25 @ 6:00 pm – 8:00 pm

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

Wednesday, October 25, 2017

5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting

Cincinnati Marriott at RiverCenter
10 West RiverCenter Boulevard
Covington, KY, 41011
Meeting Room: Covington III

PROGRAM FEATURES

  • Create your own Personalized Poster
  • Interactive, case-based learning environment
  • iPads provided to enhance learning experience
  • 3D videos and glasses provided for all attendees

FACULTY

M. Susan Burke, MD, FACP
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, PA

Vincent Martin, MD
Professor of Medicine
Department of Internal Medicine
University of Cincinnati
Director of the Headache and Facial Pain Center
University of Cincinnati Gardner Neuroscience Institute
Cincinnati, OH

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
  • Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
  • Discuss the established acute and preventive therapeutic options for patients with migraine.
  • Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

PHARMACISTS

Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of  continuing pharmacy education.  Successful completion of this program qualifies for up to 2 contact hours.  Full attendance is required.  No partial contact hours will be awarded for partial attendance. UAN: 0453-9999-17-349-L04(K)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Nov
4
Sat
Summit Meeting – Los Angeles, CA @ JW Marriott L.A. LIVE
Nov 4 @ 8:00 am – 10:00 am

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

Saturday, November 04, 2017

7:30 AM – 8:00 AM Registration/Breakfast
8:00 AM – 10:00 AM Meeting

JW Marriott Los Angeles L.A. LIVE
900 West Olympic Boulevard
Los Angeles, CA, 90015
Meeting Room: Plaza II & III

PROGRAM FEATURES

  • Create your own Personalized Poster
  • Interactive, case-based learning environment
  • iPads provided to enhance learning experience
  • 3D videos and glasses provided for all attendees

FACULTY

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

M. Susan Burke, MD, FACP
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, Pennsylvania

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
  • Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
  • Discuss the established acute and preventive therapeutic options for patients with migraine.
  • Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Nov
6
Mon
Summit Meeting – Miami, FL @ Miami Marriott Biscayne Bay
Nov 6 @ 6:00 pm – 8:00 pm

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

(Simulcast)
Thursday, September 14, 2017

5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting

Miami Marriott Biscayne Bay
1633 N Bayshore Drive
Miami, FL, 33132-1215
Meeting Room: Salon F

PROGRAM FEATURES

  • Create your own Personalized Poster
  • Interactive, case-based learning environment
  • iPads provided to enhance learning experience
  • 3D videos and glasses provided for all attendees

FACULTY

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

Anne H. Calhoun, MD, FAHS
Partner/Co-Founder, Carolina Headache Institute
Professor, Department of Anesthesiology
Professor, Department of Psychiatry
University of North Carolina
Chapel Hill, NC

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
  • Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
  • Discuss the established acute and preventive therapeutic options for patients with migraine.
  • Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

PHARMACISTS

Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of  continuing pharmacy education.  Successful completion of this program qualifies for up to 2 contact hours.  Full attendance is required.  No partial contact hours will be awarded for partial attendance. UAN: 0453-9999-17-347-L04(K)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Nov
11
Sat
Summit Meeting – New York, NY @ New York Marriott Marquis
Nov 11 @ 8:00 am – 10:00 am

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

Saturday, November 11, 2017

7:30 AM – 8:00 AM Registration/Breakfast
8:00 AM – 10:00 AM Meeting

New York Marriott Marquis
1535 Broadway
New York, NY  10036
Meeting Room: Marquis Ballroom (located on the 9th floor)

PROGRAM FEATURES

  • Create your own Personalized Poster
  • Interactive, case-based learning environment
  • iPads provided to enhance learning experience
  • 3D videos and glasses provided for all attendees

FACULTY

Anne Calhoun, MD, FASH
Partner/Co-Founder, Carolina Headache Institute
Professor, Department of Anesthesiology
Professor, Department of Psychiatry
University of North Carolina
Chapel Hill, NC

Stewart J. Tepper, MD, FAHS
Professor of Neurology
Geisel School of Medicine at Dartmouth
Hanover, NH

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
  • Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
  • Discuss the established acute and preventive therapeutic options for patients with migraine.
  • Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Nov
29
Wed
Summit Meeting – Atlanta, GA @ Atlanta Marriott Marquis
Nov 29 @ 6:00 pm – 8:00 pm

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

Wednesday, November 29, 2017

5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting

Atlanta Marriott Marquis
265 Peachtree Center Avenue
Atlanta, GA, 30303
Meeting Room: A601 on the Atrium Level

PROGRAM FEATURES

  • Create your own Personalized Poster
  • Interactive, case-based learning environment
  • iPads provided to enhance learning experience
  • 3D videos and glasses provided for all attendees

FACULTY

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

Andrew Charles, MD
Director Meyer and Renee Luskin Chair
Migraine and Headache Studies
UCLA Medical Center
Los Angeles, CA

 

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
  • Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
  • Discuss the established acute and preventive therapeutic options for patients with migraine.
  • Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

PHARMACISTS

Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this program qualifies for up to 2 contact hours. Full attendance is required. No partial contact hours will be awarded for partial attendance. UAN: 0453-9999-17-307-L04-(K)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Dec
5
Tue
Summit Meeting – Nashville, TN @ Renaissance Nashville Hotel
Dec 5 @ 6:00 pm – 8:00 pm

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

Tuesday, December 05, 2017

5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting

Renaissance Nashville Hotel
611 Commerce Street
Nashville, TN, 37203
Meeting Room: Music City Ballroom

PROGRAM FEATURES

  • Create your own Personalized Poster
  • Interactive, case-based learning environment
  • iPads provided to enhance learning experience
  • 3D videos and glasses provided for all attendees

FACULTY

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

M. Susan Burke, MD, FACP
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Philadelphia, PA

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
  • Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
  • Discuss the established acute and preventive therapeutic options for patients with migraine.
  • Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Dec
7
Thu
Grand Rounds – Binghamton, NY @ Our Lady of Lourdes Memorial Hospital Inc.
Dec 7 @ 12:00 pm – 1:00 pm

Location:

Our Lady of Lourdes Memorial Hospital Inc.
169 Riverside Drive
Binghamton, NY 13905
Meeting Room: Lecture Hall, Main Floor
Time: 12:00 pm – 1:00 pm

Speaker:

Dawn C. Buse, PhD
Professor, Department of Neurology
Albert Einstein College of Medicine of Yeshiva University
Assistant Professor, Clinical Health Psychology Doctoral Program
Ferkauf Graduate School of Psychology of Yeshiva University
Director of Behavioral Medicine
Montefiore Headache Center
New York, NY

Oct
7
Sun
Summit Meeting – San Diego, CA @ Marriott Marquis San Diego Marina
Oct 7 @ 6:00 pm – 7:45 pm

A 3D View: Improving Acute Preventive Treatment of Migraine in Primary Care Setting Using Novel Agents

Sunday, October 07, 2018

6:00 PM – 6:30 PM Registration/Dinner
6:30 PM – 7:45 PM Meeting

VENUE

Marriott Marquis San Diego Marina
333 West Harbor Drive
San Diego, CA 92101
Meeting Room: Ballroom 5-9

PROGRAM FEATURES

  • 1.15 CME Credits: A 3D View!
  • 3D Glasses Provided to all attendees
  • Interactive, case-based learning environment
  • Create your own Personalized Poster

REGISTRATION INFORMATION

To register for the live event meeting or simulcast, please visit www.MLG-Migraine.com or call 2017-406-4248.

FACULTY

Anne H. Calhoun, MD, FAHS
Partner/Co-Founder, Carolina Headache Institute
Professor, Department of Anesthesiology
Professor, Department of Psychiatry
University of North Carolina
Chapel Hill, NC

Andrew Charles, MD
Professor of Neurology
Director, UCLA Goldberg Migraine Program
Meyer and Renee Luskin Chair in Migraine and Headache Studies
David Geffen School of Medicine at
University of California,
Los Angeles, LA

AGENDA

I. Migraine: Overview

  • The burden of migraine: epidemiology, disability and quality of life, economic burden
  • Migraine pathophysiology
  • Migraine and other primary headaches: classification and diagnosis
  • Challenges of differential diagnosis

II. The Current Challenges and Needs in Migraine Management

  • Expanding role for primary care providers and doctors of osteopathy
  • Evidence-based approach to acute and preventive treatment of migraine
  • Abortive agents in development: lasmiditan, gepants, new delivery devices for existing agents
  • Migraine prevention: what are the current unmet needs?
  • Patient segmentation: identifying the patients with refractory chronic migraine

Patient video showing the process of differential diagnosis – leading in to treatment

III. Targeting CGRP or Its Receptor: A New Era in Targeting Migraine Underlying Pathology

  • Role of CGRP in the trigeminovascular system and in migraine
    • Mechanism of action of gepants and mAbs to CGRP or its receptor
  • Update of recently released data from clinical trials
  • Safety
  • Patient-reported outcomes
  • Adherence, persistence and cost-effectiveness, impact on access
  • Interactive case studies, including refractory chronic migraine cases

IV. Neuromodulation: A Brief Update

V. Clinician-patient Communication: Case-based Discussion

  • Improving patient/physician and physician/physician communication

VI. “Conclusions and Questions & Answers

EDUCATIONAL OBJECTIVES

  • Review best practices for diagnosing migraine headaches including the process of differential diagnosis
  • Assess efficacy and safety profiles of investigational agents for the acute treatment of migraine, as well as calcitonin-gene related peptide (CGRP)-targeting agents for the prevention of episodic and chronic migraine
  • Describe burdens associated with migraine headaches and the use of patient reported outcomes for measuring the impact of new and established migraine therapies
  • Discuss strategies for managing migraine that include the integration of novel treatment options and the application of methods for

TARGET AUDIENCE

This activity is intended for primary care providers and doctors of osteopathy working with patients with migraine headaches.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.15 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in treating and managing patients with migraine. CNE Credits: 1.15 ANCC Contact Hours

CNE Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.15 MOC in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

AOA CREDIT

Med Learning Group will apply to the American Osteopathic Association (AOA) Council on Continuing Medical Education to approve this symposium for AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Jan
30
Wed
Summit Meeting – Miami, FL @ JW Marriott Marquis Miami
Jan 30 @ 5:30 pm – 7:30 pm

A 3D View: Improving Acute Preventive Treatment of Migraine in Primary Care Setting Using Novel Agents

WEDNESDAY, JANUARY 30, 2019

5:30 PM – 6:00 PM Registration / Dinner
6:00 PM – 7:30 PM Meeting

VENUE

JW Marriott Marquis Miami
255 Biscayne Blvd Way
Miami, FL 33131
Meeting Room: Plaza 4 & 5

1.5 CME/CNE Credits: A 3D View!

  • 3D GLASSES PROVIDED TO ALL ATTENDEES

Features:

  • Interactive, case-based learning environment
  • Create your own Personalized Poster
  • iPads provided to enhance learning experience and enable real-time Q&A

REGISTRATION INFORMATION

To register for the live event meeting or simulcast, please visit www.MLG-Migraine.com or call 207-406-4248.

FACULTY

Anne H. Calhoun, MD, FAHS
Partner/Co-Founder, Carolina Headache Institute
Professor, Department of Anesthesiology
Professor, Department of Psychiatry
University of North Carolina
Chapel Hill, NC 

Andrew Charles, MD
Professor of Neurology
Director, UCLA Goldberg Migraine Program
Meyer and Renee Luskin Chair in Migraine and Headache Studies
David Geffen School of Medicine at
University of California
Los Angeles, LA

AGENDA

I. Overview of headache disorders

  • The burden of migraine: epidemiology, disability and quality of life, economic burden
  • Migraine and other primary headaches: classification and diagnosis of primary headache disorders
  • Patient video showing the process of differential diagnosis – leading into treatment

II The current challenges and needs in migraine management

  • Expanding role for primary care providers and doctors of osteopathy
  • Evidence-based approach to acute and preventive treatment of migraine
  • Abortive agents in development: lasmiditan, gepants, new delivery devices for existing agents
  • Migraine prevention: what are the current unmet needs?
  • Improving patient/physician and physician/physician communication

III. Targeting CGRP or its receptor: a new era in targeting migraine underlying pathology

  • Role of CGRP in the trigeminovascular system and in migraine
    • Mechanism of action of gepants and mAbs to CGRP or its receptor
  • Update of recently released data from clinical trials
  • Safety
  • Patient-reported outcomes
  • Interactive case studies, including refractory chronic migraine cases
  • Improving patient/physician and physician/physician communication

IV. Neuromodulation: a brief update

V. Conclusions and Q&A

EDUCATIONAL OBJECTIVES

  • Review best practices for diagnosing migraine headaches including the process of differential diagnosis
  • Assess efficacy and safety profiles of investigational agents for the acute treatment of migraine, as well as calcitonin-gene related peptide (CGRP)-targeting agents for the prevention of episodic and chronic migraine
  • Describe burdens associated with migraine headaches and the use of patient-reported outcomes for measuring the impact of new and established migraine therapies
  • Discuss strategies for managing migraine that include the integration of novel treatment options and the application of methods for overcoming patient- and physician-dependent barriers in clinical practice

TARGET AUDIENCE
This activity is intended for primary care providers and doctors of osteopathy working with patients with migraine headaches.

ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in treating and managing patients with migraine. CNE Credits: 1.5 ANCC Contact Hours

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ABIM Maintenance of Certification:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 AOA Credit:
The AOA Bureau of OMED is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The AOA Bureau of OMED, as a co-sponsor with Med Learning Group, designates this live program for a maximum of 1.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participant in this live activity.

DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/ 

AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Feb
6
Wed
Summit Meeting – San Diego, CA @ THE WESTIN SAN DIEGO
Feb 6 @ 5:30 pm – 7:30 pm

A 3D View: Improving Acute Preventive Treatment of Migraine in Primary Care Setting Using Novel Agents

WEDNESDAY, FEBRUARY 6, 2019

5:30 PM – 6:00 PM Registration / Dinner
6:00 PM – 7:30 PM Meeting

VENUE

THE WESTIN SAN DIEGO
400 West Broadway
San Diego, CA 92101
MEETING ROOM: Emerald Ballroom

1.5 CME/CNE Credits: A 3D View!

  • 3D GLASSES PROVIDED TO ALL ATTENDEES

Features:

  • Interactive, case-based learning environment
  • Create your own Personalized Poster
  • iPads provided to enhance learning experience and enable real-time Q&A

REGISTRATION INFORMATION

To register for the live event meeting or simulcast, please visit www.MLG-Migraine.com or call 207-406-4248.

FACULTY

Anne H. Calhoun, MD, FAHS
Partner/Co-Founder, Carolina Headache Institute
Professor, Department of Anesthesiology
Professor, Department of Psychiatry
University of North Carolina
Chapel Hill, NC

Andrew Charles, MD
Professor of Neurology
Director, UCLA Goldberg Migraine Program
Meyer and Renee Luskin Chair in Migraine and Headache Studies
David Geffen School of Medicine at
University of California
Los Angeles, LA

AGENDA

I. Overview of headache disorders

  • The burden of migraine: epidemiology, disability and quality of life, economic burden
  • Migraine and other primary headaches: classification and diagnosis of primary headache disorders
  • Patient video showing the process of differential diagnosis – leading into treatment

II. The current challenges and needs in migraine management

  • Expanding role for primary care providers and doctors of osteopathy
  • Evidence-based approach to acute and preventive treatment of migraine
  • Abortive agents in development: lasmiditan, gepants, new delivery devices for existing agents
  • Migraine prevention: what are the current unmet needs?
  • Improving patient/physician and physician/physician communication

III. Targeting CGRP or its receptor: a new era in targeting migraine underlying pathology

  • Role of CGRP in the trigeminovascular system and in migraine
    • Mechanism of action of gepants and mAbs to CGRP or its receptor
  • Update of recently released data from clinical trials
  • Safety
  • Patient-reported outcomes
  • Interactive case studies, including refractory chronic migraine cases
  • Improving patient/physician and physician/physician communication

IV. Neuromodulation: a brief update

V. Conclusions and Q&A

EDUCATIONAL OBJECTIVES

  • Review best practices for diagnosing migraine headaches including the process of differential diagnosis
  • Assess efficacy and safety profiles of investigational agents for the acute treatment of migraine, as well as calcitonin-gene related peptide (CGRP)-targeting agents for the prevention of episodic and chronic migraine
  • Describe burdens associated with migraine headaches and the use of patient-reported outcomes for measuring the impact of new and established migraine therapies
  • Discuss strategies for managing migraine that include the integration of novel treatment options and the application of methods for overcoming patient- and physician-dependent barriers in clinical practice

TARGET AUDIENCE
This activity is intended for primary care providers and doctors of osteopathy working with patients with migraine headaches.

ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in treating and managing patients with migraine. CNE Credits: 1.5 ANCC Contact Hours

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ABIM Maintenance of Certification:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 AOA Credit:
The AOA Bureau of OMED is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The AOA Bureau of OMED, as a co-sponsor with Med Learning Group, designates this live program for a maximum of 1.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participant in this live activity.

DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Jul
2
Thu
Diagnosing and Managing Primary Headache Disorders in the Primary Care Setting: Challenges and Opportunities
Jul 2 2020 @ 3:10 am – Jul 2 2021 @ 4:10 am

Diagnosing and Managing Primary Headache Disorders in the Primary Care Setting: Challenges and Opportunities

View Activity

FACULTY

Dawn Buse, PhD
Clinical Professor, Department of Neurology
Albert Einstein College of Medicine of Yeshiva University
Assistant Professor, Clinical Health Psychology Doctoral Program
Ferkauf Graduate School of Psychology of Yeshiva University
Board Member at Large, American Headache Society

Andrew Charles, MD
Professor of Neurology
Director, UCLA Goldberg Migraine Program
Meyer and Renee Luskin Chair in Migraine and Headache Studies
David Geffen School of Medicine at
University of California
Los Angeles, CA
President-Elect, American Headache Society

PROGRAM OVERVIEW

This case-based enduring activity will cover the treatment and management of patients with headache disorders, including migraine and cluster headache.

TARGET AUDIENCE

This activity is intended for primary care providers, including family practice physicians, physician assistants, and nurse practitioners who are involved in the care of patients with headache disorders, including migraine and cluster headache.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Implement best practices for the timely and accurate diagnosis of primary headache disorders in primary care settings and for referral to specialists when necessary
  • Identify the mechanisms of action and clinical profiles of new and emerging therapeutic options for the acute and preventative treatment of patients with primary headache disorders
  • Design individualized evidence-based treatment plans for patients with primary headache disorders, with focus on cluster headache, in the primary care setting
  • Utilize patient-specific factors to select therapies for patients with primary headache disorders, including quality-of-life assessment and goal setting
  • Implement strategies to effectively communicate with patients and educate them in order to establish treatment plans and encourage adherence

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this web-based activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with headache disorders, including migraine and cluster headache. CNE Credit: 1.0 ANCC Contact Hour.

CNE ACCREDITATION STATEMENT:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

AMERICAN ASSOCIATION OF FAMILY PHYSICIANS

This activity, Diagnosing and Managing Primary Headache Disorders in the Primary Care Setting: Challenges and Opportunities from 06/29/2020–10/31/2020, has been reviewed and is acceptable for up to 1.00 elective credit by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMERICAN ASSOCIATION OF PHYSICIAN ASSISTANTS

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid from 6/29/2020 to 10/31/2021. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-200671

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturers of any commercial products and/or providers of commercial services that are discussed in an educational activity.

DISCLOSURE OF FINANCIAL RELATIONSHIPS

FACULTY
Dawn Buse, PhD has received consulting fees from Amgen, Allergan, Biohaven, Dr. Reddy’s, Lilly, and Teva and research grant support from Amgen, Allergan, Dr. Reddy’s, and Lilly.

Andrew Charles, MD receives consulting fees from Alder, Amgen, Biohaven, Eli Lilly, and eNeura. He has conducted research for Takeda Pharmaceuticals.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer-reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
Ashley Whitehurst, Program Manager of Med Learning Group, has nothing to disclose.
Chris Drury, Medical Director of Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
Brianna Hanson, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures;
2. Participate in the enduring activity; and
3. Complete pre-and-post surveys and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

RELEASE DATE: July 2, 2020

EXPIRATION DATE: July 2, 2021

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

View Activity

Oct
26
Mon
Diagnosing and Managing Primary Headache Disorders in the Primary Care Setting: Challenges and Opportunities
Oct 26 2020 @ 7:28 am – Oct 26 2021 @ 8:28 am

Diagnosing and Managing Primary Headache Disorders in the Primary Care Setting: Challenges and Opportunities

View Activity

FACULTY

Dawn Buse, PhD
Clinical Professor, Department of Neurology
Albert Einstein College of Medicine of Yeshiva University
Assistant Professor, Clinical Health Psychology Doctoral Program
Ferkauf Graduate School of Psychology of Yeshiva University
Board Member at Large, American Headache Society
Andrew Charles, MD
Professor of Neurology
Director, UCLA Goldberg Migraine Program
Meyer and Renee Luskin Chair in Migraine and Headache Studies
David Geffen School of Medicine at University of California
President-Elect, American Headache Society
Los Angeles, CA

PROGRAM OVERVIEW

This case-based enduring activity will cover the treatment and management of patients with headache disorders, including migraine and cluster headache.


TARGET AUDIENCE

This activity is intended for primary care providers, including family practice physicians, physician assistants, and nurse practitioners who are involved in the care of patients with headache disorders, including migraine and cluster headache.


LEARNING OBJECTIVES

  • Implement best practices for the timely and accurate diagnosis of primary headache disorders in primary care settings and for referral to specialists when necessary
  • Identify the mechanisms of action and clinical profiles of new and emerging therapeutic options for the acute and preventative treatment of patients with primary headache disorders
  • Design individualized evidence-based treatment plans for patients with primary headache disorders, with focus on cluster headache, in the primary care setting
  • Utilize patient-specific factors to select therapies for patients with primary headache disorders, including quality-of-life assessment and goal setting
  • Implement strategies to effectively communicate with patients and educate them in order to establish treatment plans and encourage adherence

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.


CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.5 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.


NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with headache disorders, including migraine and cluster headache.
CNE Credits: 1.5 ANCC Contact Hours.


CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.5 contact hours of continuing nursing education of RNs and APNs.


DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturers of any commercial products and/or providers of commercial services that are discussed in an educational activity.


DISCLOSURE OF CONFLICTS OF INTEREST

Dawn Buse, PhD has received consulting fees from
Amgen, Allergan, Biohaven, Dr. Reddy’s, Lilly, and Teva and research grant support from Amgen, Allergan,
Dr. Reddy’s, and Lilly.
CME Content Review
The content of this activity was independently peer-reviewed.
The reviewer of this activity has nothing to disclose.
Andrew Charles, MD receives consulting fees from Alder, Amgen,
Biohaven, Eli Lilly, and eNeura. He has conducted research for Takeda Pharmaceuticals.
CNE Content Review
The content of this activity was peer-reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
Ashley Whitehurst, Program Manager of Med Learning Group, has nothing to disclose.
Chris Drury, Medical Director of Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
Brianna Hanson, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.


DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures;
  2. Participate in the enduring activity; and
  3. Complete pre-and-post surveys and evaluation.

Participants will receive their certificate as a downloadable file.


DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

RELEASE DATE: October 26, 2020

EXPIRATION DATE: October 26, 2021

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group at info@medlearninggroup.com

Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.